Accessibility Menu
 
Spire Healthcare Group Plc logo

Spire Healthcare Group Plc

(LSE) SPI

Current Price$151.60
Market Cap$61.32B
Since IPO (2014)-19%
5 Year-13%
1 Year-15%
1 Month-18%

Spire Healthcare Group Plc Financials at a Glance

Market Cap

$61.32B

Revenue (TTM)

$3.09B

Net Income (TTM)

$41.80M

EPS (TTM)

$4.05

P/E Ratio

37.17

Dividend

$2.30

Beta (Volatility)

-0.07 (Low)

Price

$151.60

Volume

711,688

Open

$151.80

Previous Close

$151.60

Daily Range

$149.40 - $152.80

52-Week Range

$140.80 - $256.50

SPI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spire Healthcare Group Plc

Industry

Healthcare Providers and Services

Employees

11,158

CEO

Justinian Joseph Ash

Headquarters

London, EC4Y 8EN, GB

SPI Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

8%

Net Income Margin

1%

Return on Equity

2%

Return on Capital

6%

Return on Assets

1%

Earnings Yield

2.69%

Dividend Yield

0.02%

Payout Ratio

56.10%

Stock Overview

Market Cap

$61.32B

Shares Outstanding

402.37M

Volume

711.69K

Short Interest

0.00%

Avg. Volume

1.63M

Financials (TTM)

Gross Profit

$599.10M

Operating Income

$142.90M

EBITDA

$262.50M

Operating Cash Flow

$219.30M

Capital Expenditure

$76.30M

Free Cash Flow

$143.00M

Cash & ST Invst.

$34.70M

Total Debt

$1.32B

Spire Healthcare Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$783.10M

+14.7%

Gross Profit

$295.20M

-4.8%

Gross Margin

37.70%

N/A

Market Cap

$61.32B

N/A

Market Cap/Employee

$3.91M

N/A

Employees

15,703

N/A

Net Income

$9.90M

-33.6%

EBITDA

$128.60M

+11.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.28B

-6.1%

Accounts Receivable

$108.00M

+8.3%

Inventory

$46.20M

+4.3%

Long Term Debt

$1.21B

+4.3%

Short Term Debt

$110.70M

+8.7%

Return on Assets

0.69%

N/A

Return on Invested Capital

6.43%

N/A

Free Cash Flow

$87.40M

+33.4%

Operating Cash Flow

$112.50M

-5.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONT.LOxford Nanopore Technologies plc
$105.40-2.86%
UPR.LUniphar plc
$352.00+0.57%
OXB.LOxford Biomedica plc
$572.00+1.06%
AGY.LAllergy Therapeutics plc
$10.80+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.78+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.45+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$50.13+0.02%
PLTRPalantir Technologies
$132.34+0.03%

Questions About SPI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.